New Journey Health Technology Group Co.,LTD (SHE:002219)
China
· Delayed Price · Currency is CNY 2.340
+0.030 (1.30%)
Apr 29, 2026, 3:04 PM CST
SHE:002219 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 7,951 | 7,194 | 8,916 | 10,335 | 12,861 | 6,827 | Upgrade
|
| Market Cap Growth | -5.83% | -19.32% | -13.72% | -19.64% | 88.39% | 106.78% | Upgrade
|
| Enterprise Value | 9,562 | 8,441 | 10,339 | 11,320 | 12,997 | 8,228 | Upgrade
|
| Last Close Price | 2.31 | 2.13 | 2.64 | 3.03 | 3.94 | 3.66 | Upgrade
|
| PE Ratio | 296.04 | 232.49 | 77.69 | 356.71 | 82.38 | - | Upgrade
|
| Forward PE | - | 59.75 | 59.75 | 59.75 | 59.75 | 59.75 | Upgrade
|
| PS Ratio | 2.67 | 2.36 | 2.35 | 2.64 | 4.07 | 2.26 | Upgrade
|
| PB Ratio | 3.92 | 3.58 | 4.37 | 4.76 | 7.28 | 4.30 | Upgrade
|
| P/TBV Ratio | 17.14 | 16.24 | 19.10 | 17.58 | 22.43 | 17.17 | Upgrade
|
| P/FCF Ratio | 65.86 | 195.58 | 68.03 | 92.90 | 276.78 | 86.89 | Upgrade
|
| P/OCF Ratio | 24.93 | 24.49 | 20.33 | 32.20 | 47.98 | 24.62 | Upgrade
|
| PEG Ratio | - | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | Upgrade
|
| EV/Sales Ratio | 3.21 | 2.77 | 2.72 | 2.89 | 4.11 | 2.73 | Upgrade
|
| EV/EBITDA Ratio | 20.19 | 19.14 | 22.14 | 29.43 | 33.68 | 64.65 | Upgrade
|
| EV/EBIT Ratio | 32.18 | 30.63 | 33.65 | 64.00 | 56.53 | - | Upgrade
|
| EV/FCF Ratio | 79.20 | 229.49 | 78.88 | 101.75 | 279.72 | 104.73 | Upgrade
|
| Debt / Equity Ratio | 0.89 | 0.93 | 0.97 | 1.11 | 0.73 | 1.23 | Upgrade
|
| Debt / EBITDA Ratio | 3.81 | 4.16 | 3.87 | 5.79 | 3.25 | 15.29 | Upgrade
|
| Debt / FCF Ratio | 14.95 | 50.91 | 15.04 | 21.61 | 27.72 | 24.86 | Upgrade
|
| Net Debt / Equity Ratio | 0.77 | 0.73 | 0.73 | 0.83 | 0.41 | -0.05 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.35 | 3.35 | 3.20 | 4.69 | 1.89 | -0.63 | Upgrade
|
| Net Debt / FCF Ratio | 12.86 | 40.14 | 11.39 | 16.20 | 15.68 | -1.02 | Upgrade
|
| Asset Turnover | 0.45 | 0.46 | 0.57 | 0.64 | 0.51 | 0.52 | Upgrade
|
| Inventory Turnover | 11.42 | 12.29 | 12.20 | 13.92 | 12.34 | 12.15 | Upgrade
|
| Quick Ratio | 0.48 | 0.49 | 0.50 | 0.52 | 0.44 | 0.60 | Upgrade
|
| Current Ratio | 0.53 | 0.54 | 0.57 | 0.59 | 0.54 | 0.66 | Upgrade
|
| Return on Equity (ROE) | 1.43% | 1.65% | 5.71% | 2.02% | 9.84% | -42.13% | Upgrade
|
| Return on Assets (ROA) | 2.80% | 2.58% | 2.89% | 1.80% | 2.33% | -0.39% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.31% | 3.37% | 6.38% | 5.47% | 10.11% | -2.17% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.60% | 8.90% | 9.80% | 5.60% | 9.90% | -1.70% | Upgrade
|
| Earnings Yield | 0.32% | 0.43% | 1.29% | 0.28% | 1.21% | -5.44% | Upgrade
|
| FCF Yield | 1.52% | 0.51% | 1.47% | 1.08% | 0.36% | 1.15% | Upgrade
|
| Payout Ratio | 367.59% | 325.46% | 103.03% | 366.45% | 176.67% | - | Upgrade
|
| Buyback Yield / Dilution | -0.64% | -0.10% | -1.02% | 0.33% | -75.08% | 0.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.